Unichem Laboratories Ltd has announced that a meeting of its Board of Directors is scheduled for Monday, August 4, 2025, to consider and approve the unaudited financial results (consolidated and standalone) for the quarter ended June 30, 2025. The announcement was made to the Bombay Stock Exchange and the National Stock Exchange of India on July 15, 2025.
The meeting will address the financial performance of Unichem Laboratories for the first quarter of the fiscal year 2026. The board will review and approve the unaudited financial results, providing stakeholders with insights into the company's performance during this period.
| Particulars | Details |
|---|---|
| Meeting Date | August 4, 2025 |
| Purpose | To consider and approve the unaudited financial results for the quarter ended June 30, 2025 |
| Financial Results | Consolidated and Standalone |
The meeting will address the financial performance of Unichem Laboratories for the first quarter of the fiscal year 2026. The board will review and approve the unaudited financial results, providing stakeholders with insights into the company's performance during this period.
The decision to hold the board meeting and the subsequent announcement are in compliance with Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates that listed companies inform the stock exchanges about board meetings where financial results and other key matters are to be discussed.
The announcement was made by Pradeep Gautam Bhandari, Head – Legal & Company Secretary of Unichem Laboratories Limited. The company has its registered office in Mumbai and is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
